Effectiveness of the NoseFrida Compared With Bulb Suction at Relieving Objective Signs of Nasal Obstruction and Reducing Return Visits in Pediatric Patients Presenting to the Emergency Department

NCT03666429 | Withdrawn FDA Device

• 1 other identifier: 181365
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The mainstay of treatment in viral upper and lower respiratory tract disease is airway clearance. Viral respiratory tract infections account for a substantial amount of emergency department (ED) visits, financial and stress burden on caregivers. In addition, they also account for a large number of ED return visits. While airway clearance is considered a mainstay of treatment the pragmatic effectiveness of various devices remain unstudied in patients who are discharged from the ED. The objectives of this study are to compare the pragmatic effectiveness of two commonly used suction devices the NoseFrida and bulb suction and to provide a descriptive analysis on 72 hour return to ED rates and readmission rates. Patients will be enrolled October 15, 2018 to October 15, 2019 or until NoseFrida supplies are depleted. Fridababy will supply 500 NoseFrida devices and replacement filters. Patients aged 1 day to 24 months presenting Vanderbilt Childrens ED with symptoms of nasal congestion or bronchiolitis who require suctioning and will be discharged from the ED will be approached for enrollment. Exclusion criteria include no upper airway abnormalities or previously enrolled in study. The study design is a prospective and retrospective observational study. We anticipate about 500 patients to be enrolled in this study. Families will then be approached for consent to participate. Caregiver will fill out a data collection form then be instructed on how to use the NoseFrida. Next, family with trial it on their child while in the ED. Caregivers will then fill out a 7 point Likert survey on both the bulb suction and NoseFrida device. The family will go home with this device and a set of replacement filters and instructed to suction their child as needed. The primary investigator (PI) will then complete a 72 hour chart review to determine the number of return to ED visits and readmission rates. To compare ED returns with retrospective data, KSP will conduct a review of the business objects database using ICD9 codes specific for viral respiratory tract infections over the past 3 years to determine a control return ED visit rate. Data will be compared using a paired T-test. If data is not normally distributed we will use a Wilcoxon signed-rank test. We will also use a multivariable logistic model to examine associations adjusted for age and illness severity.

Conditions

Upper Respiratory Tract Infections; Nasal Suction; Return Emergency Department Visits

Outcome Measures

Primary Outcomes (1)

• Parental satisfaction

  Measured on a 7 point Likert scale from 1 to 7 with 7 being strongly agree

  at baseline

Study Arms (2)

Bulb suction

ACTIVE COMPARATOR

Patients in this arm will be given bulb suction to treat nasal congestion. This group will contain participants who have used bulb suction in the past.

Device: Bulb suction

NoseFrida

EXPERIMENTAL

Patients in this arm will be given the NoseFrida to treat nasal congestion. This group will contain participants who will trial the NoseFrida in the emergency department.

Device: NoseFrida

Interventions

Bulb suction DEVICE

Parents will use the bulb suction on their child in the emergency room then complete a 7 point likert survey.

Bulb suction

NoseFrida DEVICE

Parents will use the NoseFrida in the emergency department and complete a 7 point likert survey.

NoseFrida

Eligibility Criteria

• Age: 1 Day - 24 Months
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Age 1 day-24 months presenting to the ED with a complaint of nasal congestion or symptoms of bronchiolitis who require suctioning.
• Parent/guardian has used a bulb suction device in the past.
• This is the first presentation to Vanderbilt Childrens Emergency Department for current illness.
• Patient will be discharged from the emergency room.
• Parent/Guardian is able to read English.

You may not qualify if:

• No upper airway abnormalities, i.e. cleft palate or choanal atresia.
• Previously enrolled in study.

Sponsors & Collaborators

• Vanderbilt University Medical Center: lead
• Fridababy: collaborator

Study Sites (1)

Vanderbilt Childrens Emergency Department

Nashville, Tennessee, 37232, United States

Location

MeSH Terms

Conditions

Respiratory Tract Infections

Condition Hierarchy (Ancestors)

Infections; Respiratory Tract Diseases

Study Officials

• Donald Arnold, M.D.

  Vanderbilt University Medical Center

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 9, 2018
• First Posted: September 11, 2018
• Study Start: January 1, 2020
• Primary Completion: November 1, 2020
• Study Completion: November 1, 2020
• Last Updated: December 3, 2020

Record last verified: 2020-12

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)